LeadPos: Position of Teamleader and Leadership Performance

Sponsor

University Hospital, Basel, Switzerland (Other)

Overall Status

Recruiting

CT.gov ID

NCT04824508

Collaborator

(none)

150

Enrollment

Location

Arms

Anticipated Duration (Months)

2.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.

Condition or Disease	Intervention/Treatment	Phase
Leadership	Behavioral: position	N/A

Detailed Description

participants: physicians taking part in voluntary simulator-based workshops. Teams of 3-4 are formed. One teammember is randomly allocated as teamleader design: prospective, randomized, single-blind, cross-over intervention: teamleaders are randomized and instructed to lead their team from the conventional position at the patient's head or from a remote hands-off position data analysis: will be performed from videorecordings

Study Design

Study Type:

Interventional

Anticipated Enrollment :

150 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

Single (Participant)

Primary Purpose:

Other

Official Title:

Effect of the Position of the Teamleader on Quality of Leadership and Team Performance

Actual Study Start Date :

Mar 1, 2017

Anticipated Primary Completion Date :

Jun 30, 2022

Anticipated Study Completion Date :

Dec 31, 2022

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Conventional position (head position) Leaderposition at the patient's head	Behavioral: position teamleaders are instructed to allocated position
Active Comparator: Remote position Leaderposition remote from patient and hands-off	Behavioral: position teamleaders are instructed to allocated position

Arm

Intervention/Treatment

Active Comparator: Conventional position (head position)

Leaderposition at the patient's head

Behavioral: position

teamleaders are instructed to allocated position

Active Comparator: Remote position

Leaderposition remote from patient and hands-off

Behavioral: position

teamleaders are instructed to allocated position

Outcome Measures

Primary Outcome Measures

Quantity of leadership [5 minutes]
Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire

Secondary Outcome Measures

Hands-on time [5 minutes]
Hands-on time during the first 5 minutes of the cardiac arrest
Quality of leadership [5 minutes]
Type of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:

24 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Physicians taking part in voluntary workshops

Exclusion Criteria:

refusal to participate and/or being videorecorded

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital	Basel	BS	Switzerland	4031

Sponsors and Collaborators

University Hospital, Basel, Switzerland

Investigators

Principal Investigator: Stephan Marsch, University Hospital, Basel, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University Hospital, Basel, Switzerland

ClinicalTrials.gov Identifier:

NCT04824508

Other Study ID Numbers:

4031-Sim

First Posted:

Apr 1, 2021

Last Update Posted:

May 18, 2022

Last Verified:

May 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by University Hospital, Basel, Switzerland

simulation

cardiopulmonary resuscitation

teamleader

Study Results

No Results Posted as of May 18, 2022